-
The 2003 meeting of the American Heart Association (AHA, Dallas, Texas), held here in early November, provided a window on the most recent developments in the diagnosis and treatment of heart disease, and on key new technologies that are expected to drive market trends in the future.
-
The frenzied pace of discovery in the cardiovascular sector was reflected at the American Heart Associations (AHA; Dallas, Texas) annual scientific sessions with a flurry of significant new data presented at the cavernous Orange County Convention Center during the November meeting.
-
In the wake of late-October reports of adverse events with Cordis (Miami Lakes, Florida) Cypher drug-eluting stent, the Johnson & Johnson (New Brunswick, New Jersey) unit sponsored a webcast in early December that included prominent interventional cardiologists as well as a top executive from the company.
-
GE Medical Systems (Waukesha, Wisconsin) and Guidant (Indianapolis, Indiana) have entered into a long-term relationship to advance and improve patient care.
-
Physical examinations can provide critical information unavailable by other means to help patients experiencing urgent cardiac care issues, such as heart attack or unstable chest pain, according to research conducted at the Cleveland Clinic (Cleveland, Ohio).
-
CardioGenesis (Foothill Ranch, California) reported that Chairman and Chief Executive Officer Michael Quinn has resumed the position of president, effective immediately, replacing Darrell Eckstein, who left the company to pursue other interests.
-
In what constitutes a new phase in the development of its technology for the heart assist market, Thoratec (Pleasanton, California) last month reported the start of its Phase I safety trial for its HeartMate II axial-flow left ventricular assist device.
-
-
The armamentarium of devices to shock and assist the pumping action of the heart seems to have grown rather full, with seemingly little room for new ones. Pacemakers, defibrillators, ventricular assist devices and even the artificial heart have provided an increasing range of technologies for supporting and retaining important functions and even substituting for the heart.
-
Advances in Cardiovascular Technology: Emerging Markets for the 21st Century, Vol. 2, the newest sourcebook from the publishers of Cardiovascular Device Update and The BBI Newsletter, has just been released.
